MedTrace Logo

Bringing Relief to Adolescents Naturally Using Melatonin for Migraine

NCT02344316 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-09-09

Study results available
· View outcomes & findings →

Summary

Migraine in adolescents is common and effective and safe preventive treatments are needed. This is a pilot randomized controlled trial of melatonin versus placebo for migraine prevention in adolescents 12-17 years old.

Conditions

  • Migraine in Adolescents

Interventions

DRUG

Melatonin

Taken at 9 PM or 1 hour before bedtime, whichever is earlier

OTHER

Placebo

Matching placebo taken at 9 PM or 1 hour before bedtime, whichever is earlier

Sponsors & Collaborators

Principal Investigators

  • Amy A Gelfand, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2016-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02344316 on ClinicalTrials.gov